Your browser doesn't support javascript.
loading
Foley Bulb Added to an Oral Misoprostol Induction Protocol: A Cluster Randomized Trial.
Adhikari, Emily H; Nelson, David B; McIntire, Donald D; Leveno, Kenneth J.
Afiliación
  • Adhikari EH; Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas.
Obstet Gynecol ; 136(5): 953-961, 2020 11.
Article en En | MEDLINE | ID: mdl-33030881
OBJECTIVE: To evaluate whether the induction of labor in term gravid women with cervical dilation 2 cm or less and intact membranes by using oral misoprostol preceded by transcervical Foley bulb placement results in a significantly increased vaginal delivery rate compared with the use of oral misoprostol alone. METHODS: We randomized the induction method by week of admission to labor and delivery, with each week group described as a cluster in a block randomized design. Women with gestational age of 37 weeks or greater, cervical dilation 2 cm or less, intact membranes, and indication for labor induction were included. Study arms were either 100 micrograms of oral misoprostol after transcervical Foley bulb placement or 100 micrograms of oral misoprostol alone. The primary outcome was vaginal delivery with the first induction attempt. Secondary outcomes included time to delivery, clinical chorioamnionitis (maternal temperature of 38°C or greater during labor with or without fundal tenderness, without other identified cause), cesarean delivery indication, and adverse outcomes. We estimated that a sample size of 1,077 per arm was needed to detect a 5% increase in vaginal delivery rate with a type I error of 5% and power of 80%, accounting for interim analysis and cluster size of 30 inductions per week. This was a pragmatic trial, and analysis was by intention-to-treat. RESULTS: From January 1, 2018, to May 13, 2019, 1,117 women (34 clusters) were assigned to oral misoprostol plus Foley and 1,110 women (34 clusters) to oral misoprostol alone. Demographic characteristics were similar. Vaginal delivery at the first induction occurred in 78% of the misoprostol plus Foley arm and in 77% of the misoprostol arm (relative risk [RR] 1.00; 95% CI 0.96-1.05; adjusted relative risk [aRR], 1.00; 95% CI 0.95-1.05). Clinical chorioamnionitis occurred in 18% of the misoprostol plus Foley arm and in 14% of the misoprostol arm (RR 1.30; 95% CI 1.07-1.58; aRR 1.30; 95% CI 1.08-1.56). There were no differences in neonatal outcomes. CONCLUSION: Induction of labor in gravid women at term with intact membranes by using oral misoprostol plus Foley bulb did not result in a higher vaginal delivery rate, but it did result in more clinical chorioamnionitis compared with the use of oral misoprostol alone. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03407625.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxitócicos / Misoprostol / Sistemas de Liberación de Medicamentos / Parto Obstétrico / Trabajo de Parto Inducido Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Obstet Gynecol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxitócicos / Misoprostol / Sistemas de Liberación de Medicamentos / Parto Obstétrico / Trabajo de Parto Inducido Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Obstet Gynecol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos